Isogenica today announced the appointment of Dr David Mead as Director of Business Development effective immediately.  Dr Mead was previously Business Development Director at Albumedix where he was...

Isogenica today announced an expansion of the collaboration and license agreement signed with Aro Biotherapeutics in June 2018.Under the expanded agreement, Isogenica will use its CIS Display...

Isogenica Ltd, a leader in the design and construction of diverse, fully synthetic, antibody libraries for biopharmaceutical discovery, today announced that Dr Emma Sceats has been appointed Chief...